ASPA report highlights trends in pharma crime

The menace of substandard and falsified (SF) medical products is not new. Unfortunately, however, the issue is still undervalued and undertreated. Counterfeiting and illicit trade plague all industries, but pharmaceuticals and healthcare are among the most prominent victims, especially when there is a matter of life and death.

by Rahul Kumar